Trial Profile
Short-term add-on Therapy With Angiotensin Receptor Blocker for End-stage Inotrope-dependent Heart Failure Patients: B-type Natriuretic Peptide Reduction in a Randomized Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2013
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; ACE inhibitors; Dobutamine
- Indications Decompensated heart failure
- Focus Pharmacodynamics; Therapeutic Use
- 28 May 2013 New trial record